![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
Expiry update challenges in a changing label landscape
By Fisher Clinical Services
As the implementation of a new Annex VI European labelling regulation approaches, Clinical Trials Insight talks to industry experts to review its impact on supply chain management. Jennifer Worsfold, senior director of supply chain solutions and strategic projects, and Elizabeth Gallagher, director of global logistics at Fisher Clinical Services; and Mike Donahue, senior label programme director of Clintrak Clinical Labeling, share best practices on how to manage these changes.
![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)